Skip to playerSkip to main content
  • 21 hours ago
ByHeart recalled all infant formula after California health officials linked two lots to a multi-state infant botulism outbreak. Fifteen infants were hospitalized, and FDA testing found Clostridium botulinum spores in leftover product as the agency expanded its investigation.
Transcript
00:00It's Benzinga, bringing Wall Street to Main Street.
00:02Bayard recalled all of its infant formula after California health officials linked the multi-state infant botulism outbreak to two initial lots,
00:09probing an expanded investigation with the FDA, according to Ars Technica.
00:1315 hospitalized infants across 12 states had received Bayard formula in state testing of leftover product catching clostridium botulism spores.
00:21The company broadened its recall following late-night discussions with the FDA, citing unresolved concerns despite no confirmed contamination in unopened cans.
00:30The FDA said Bayard accounts for about 1% of U.S. formula sales, yet babies given the product represented over 40% of this year's formula-length infant botulism cases.
00:39For all things money, visit Benzinga.com.
Be the first to comment
Add your comment

Recommended